nodes	percent_of_prediction	percent_of_DWPC	metapath
Drostanolone—SHBG—Nongenotropic Androgen signaling—PTK2—malignant glioma	0.0437	0.0439	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—POR—malignant glioma	0.0426	0.0428	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—LATS2—malignant glioma	0.0421	0.0423	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—AREG—malignant glioma	0.027	0.0271	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—XBP1—malignant glioma	0.0267	0.0268	CbGpPWpGaD
Drostanolone—CYP19A1—Tryptophan metabolism—ASMT—malignant glioma	0.0261	0.0262	CbGpPWpGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—RAF1—malignant glioma	0.0249	0.025	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—HEY2—malignant glioma	0.0199	0.02	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—CYP2C18—malignant glioma	0.0194	0.0195	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—HEY1—malignant glioma	0.0184	0.0185	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—MYB—malignant glioma	0.0177	0.0178	CbGpPWpGaD
Drostanolone—CYP19A1—Tryptophan metabolism—CYP2C18—malignant glioma	0.0161	0.0162	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.015	0.0151	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.0148	0.0149	CbGpPWpGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—PIK3CA—malignant glioma	0.0148	0.0149	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—PTK2—malignant glioma	0.0135	0.0136	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.013	0.0131	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.0129	0.0129	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—malignant glioma	0.0124	0.0125	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.0122	0.0122	CbGpPWpGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—AKT1—malignant glioma	0.0121	0.0122	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—SOD1—malignant glioma	0.0111	0.0112	CbGpPWpGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—NCOR1—malignant glioma	0.0111	0.0111	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.0106	0.0106	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—HES1—malignant glioma	0.00953	0.00958	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—NCOR1—malignant glioma	0.00948	0.00952	CbGpPWpGaD
Drostanolone—CYP19A1—Tryptophan metabolism—CAT—malignant glioma	0.00879	0.00883	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAE—malignant glioma	0.00869	0.00873	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—PPARG—malignant glioma	0.00805	0.00809	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.008	0.00804	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—HIF1A—malignant glioma	0.00799	0.00802	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.00776	0.00779	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—RAF1—malignant glioma	0.00771	0.00774	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—KDR—malignant glioma	0.00764	0.00767	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—RAF1—malignant glioma	0.00741	0.00744	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.00735	0.00738	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—NF1—malignant glioma	0.00723	0.00726	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—NOTCH1—malignant glioma	0.0072	0.00723	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—PLK1—malignant glioma	0.00709	0.00712	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—MYB—malignant glioma	0.00678	0.00681	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.00655	0.00658	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP2B6—malignant glioma	0.00647	0.0065	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—malignant glioma	0.00647	0.00649	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MSH2—malignant glioma	0.00641	0.00644	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP2B6—malignant glioma	0.00638	0.00641	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.00636	0.00639	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—NF1—malignant glioma	0.00622	0.00625	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—NCOR1—malignant glioma	0.00613	0.00616	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—PLK1—malignant glioma	0.0061	0.00613	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—PML—malignant glioma	0.00599	0.00602	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.00588	0.0059	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—PTK2—malignant glioma	0.00582	0.00585	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—NCOR1—malignant glioma	0.00569	0.00571	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP2C18—malignant glioma	0.00561	0.00563	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.00557	0.0056	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP2C18—malignant glioma	0.00553	0.00556	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MSH2—malignant glioma	0.00552	0.00554	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—malignant glioma	0.00546	0.00548	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—PML—malignant glioma	0.00516	0.00518	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.00509	0.00512	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.00509	0.00512	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—MDM2—malignant glioma	0.00503	0.00506	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.00497	0.00499	CbGpPWpGaD
Drostanolone—CYP19A1—Tryptophan metabolism—MDM2—malignant glioma	0.00485	0.00487	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—CDKN2A—malignant glioma	0.00464	0.00466	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—CAV1—malignant glioma	0.00464	0.00466	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—malignant glioma	0.0046	0.00462	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—PIK3CA—malignant glioma	0.00459	0.00461	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.00454	0.00456	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—GSTT1—malignant glioma	0.00454	0.00456	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—PTGS1—malignant glioma	0.00425	0.00427	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.00419	0.00421	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—STAT3—malignant glioma	0.00417	0.00419	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—malignant glioma	0.00408	0.00409	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—BRCA2—malignant glioma	0.00396	0.00398	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—AKT1—malignant glioma	0.00375	0.00376	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—malignant glioma	0.00373	0.00375	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—HES1—malignant glioma	0.00365	0.00367	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—AKT1—malignant glioma	0.0036	0.00362	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.00353	0.00355	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—malignant glioma	0.00341	0.00343	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—malignant glioma	0.00339	0.0034	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—MDM2—malignant glioma	0.00333	0.00334	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.00328	0.0033	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.00325	0.00327	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—RTEL1—malignant glioma	0.00318	0.00319	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—GSTP1—malignant glioma	0.00314	0.00316	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—GSTP1—malignant glioma	0.0031	0.00311	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—malignant glioma	0.00306	0.00308	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.00306	0.00307	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.00296	0.00297	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—BAD—malignant glioma	0.00286	0.00287	CbGpPWpGaD
Drostanolone—Methyltestosterone—CYP2B6—malignant glioma	0.0028	0.633	CrCbGaD
Drostanolone—AR—Androgen receptor signaling pathway—PTEN—malignant glioma	0.0028	0.00281	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.00264	0.00265	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—BRAF—malignant glioma	0.0026	0.00261	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—malignant glioma	0.00253	0.00254	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—malignant glioma	0.00251	0.00252	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—STAT3—malignant glioma	0.0025	0.00251	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—BAD—malignant glioma	0.00246	0.00247	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00237	0.00238	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00229	0.0023	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—EGFR—malignant glioma	0.00227	0.00228	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00227	0.00228	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00227	0.00228	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—BRAF—malignant glioma	0.00224	0.00225	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—BCL2—malignant glioma	0.00221	0.00222	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.0022	0.00221	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—AKT1—malignant glioma	0.00218	0.00219	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MDM2—malignant glioma	0.00218	0.00219	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—NOTCH3—malignant glioma	0.0021	0.00211	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.00198	0.00199	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CASP3—malignant glioma	0.00195	0.00196	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.00193	0.00194	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.0019	0.00191	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—BCL2—malignant glioma	0.0019	0.00191	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.0019	0.00191	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—NOTCH2—malignant glioma	0.00188	0.00189	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MDM2—malignant glioma	0.00187	0.00188	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.00183	0.00184	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—PTEN—malignant glioma	0.00183	0.00184	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—COX8A—malignant glioma	0.00183	0.00183	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.00181	0.00181	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.0018	0.00181	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.00178	0.00179	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.00174	0.00175	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	0.00174	0.00175	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—malignant glioma	0.00168	0.00169	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.00165	0.00166	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00163	0.00164	CbGpPWpGaD
Drostanolone—Testosterone—CYP2B6—malignant glioma	0.00162	0.367	CrCbGaD
Drostanolone—AR—Generic Transcription Pathway—CDKN2B—malignant glioma	0.00162	0.00162	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.00162	0.00162	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.00161	0.00162	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—AKT1—malignant glioma	0.00161	0.00162	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—PTEN—malignant glioma	0.00158	0.00158	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ASMT—malignant glioma	0.00155	0.00156	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—NCOR1—malignant glioma	0.00153	0.00154	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.00152	0.00153	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.00152	0.00152	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.00152	0.00152	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.00149	0.0015	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—BCAN—malignant glioma	0.00146	0.00147	CbGpPWpGaD
Drostanolone—AR—Gene Expression—DNMT3B—malignant glioma	0.00143	0.00144	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.00142	0.00143	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.00141	0.00141	CbGpPWpGaD
Drostanolone—AR—Gene Expression—HIST1H3B—malignant glioma	0.00139	0.0014	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—TNF—malignant glioma	0.00138	0.00139	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.00137	0.00138	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.00131	0.00132	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.00128	0.00129	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.00126	0.00127	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.00125	0.00126	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.00123	0.00124	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.00121	0.00122	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—IDH2—malignant glioma	0.00118	0.00118	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.00118	0.00118	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.00117	0.00117	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—NOTCH1—malignant glioma	0.00116	0.00117	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.00111	0.00111	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP2B6—malignant glioma	0.00111	0.00111	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—PPARG—malignant glioma	0.0011	0.0011	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.00108	0.00108	CbGpPWpGaD
Drostanolone—AR—Gene Expression—H3F3A—malignant glioma	0.00108	0.00108	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.00107	0.00108	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.00106	0.00106	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.00104	0.00104	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—IDH1—malignant glioma	0.00101	0.00102	CbGpPWpGaD
Drostanolone—AR—Gene Expression—NOTCH3—malignant glioma	0.00101	0.00101	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SPHK1—malignant glioma	0.000979	0.000983	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP2C18—malignant glioma	0.000959	0.000963	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.000908	0.000912	CbGpPWpGaD
Drostanolone—AR—Gene Expression—NOTCH2—malignant glioma	0.000906	0.00091	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000904	0.000908	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000875	0.000879	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000824	0.000827	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000795	0.000799	CbGpPWpGaD
Drostanolone—AR—Gene Expression—CDKN2B—malignant glioma	0.000778	0.000782	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GSTT1—malignant glioma	0.000776	0.000779	CbGpPWpGaD
Drostanolone—AR—Gene Expression—NCOR1—malignant glioma	0.000738	0.000742	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PTGS1—malignant glioma	0.000727	0.00073	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000724	0.000727	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—BCHE—malignant glioma	0.000676	0.000679	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SLC5A5—malignant glioma	0.000667	0.00067	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000631	0.000634	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—MYC—malignant glioma	0.000627	0.000629	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000625	0.000628	CbGpPWpGaD
Drostanolone—AR—Gene Expression—NOTCH1—malignant glioma	0.000561	0.000563	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000545	0.000548	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GSTP1—malignant glioma	0.000538	0.00054	CbGpPWpGaD
Drostanolone—AR—Gene Expression—PPARG—malignant glioma	0.000529	0.000532	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CAT—malignant glioma	0.000523	0.000525	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—NCOR1—malignant glioma	0.000494	0.000496	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CAV1—malignant glioma	0.000403	0.000405	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000385	0.000386	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIK3CG—malignant glioma	0.000367	0.000368	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PPARG—malignant glioma	0.000354	0.000356	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIK3CD—malignant glioma	0.000322	0.000324	CbGpPWpGaD
Drostanolone—AR—Gene Expression—MYC—malignant glioma	0.000302	0.000303	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIK3CB—malignant glioma	0.000281	0.000282	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PTGS2—malignant glioma	0.000279	0.00028	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PTEN—malignant glioma	0.000243	0.000244	CbGpPWpGaD
Drostanolone—AR—Gene Expression—AKT1—malignant glioma	0.000209	0.00021	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIK3CA—malignant glioma	0.000171	0.000172	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AKT1—malignant glioma	0.00014	0.000141	CbGpPWpGaD
